ClinicalTrials.Veeva
Menu

Find clinical trials for Lymphoma in Seattle, WA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Lymphoma
Leukemia
Non-Hodgkin Lymphoma
Lymphoid Leukemia
Diffuse Large B-Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Cell Chronic Lymphocytic Leukemia

Lymphoma trials near Seattle, WA, USA:

Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma

a standard 3+3 design. Once the maximum tolerated dose (MTD) is determined amongst patients with relapsed or refractory grade 1-3a follicular lymphoma...

Active, not recruiting
Relapsed Follicular Lymphoma
Refractory Follicular Lymphoma
Drug: Venetoclax
Drug: Ibrutinib

Phase 1, Phase 2

Georgetown University
Georgetown University

Seattle, Washington, United States and 2 other locations

This is a Phase 1/2 study of imvotamab in adult subjects with relapsed or refractory B-cell Non-Hodgkin Lymphoma. This study will consist of...

Active, not recruiting
Marginal Zone Lymphoma
Mantle Cell Lymphoma
Drug: imvotamab

Phase 1, Phase 2

IGM Biosciences

Seattle, Washington, United States and 26 other locations

SC262-101 is a Phase 1 study to evaluate SC262 safety and tolerability, anti-tumor activity, cellular kinetics, immunogenicity, and exploratory bioma...

Enrolling
Large B-cell Lymphoma
Non Hodgkin's Lymphoma
Drug: SC262

Phase 1

Sana Biotechnology

Seattle, Washington, United States

Follicular lymphoma (FL), marginal zone lymphoma (MZL), and mantle cell lymphoma (MCL) are distinct histologic types of B-...

Active, not recruiting
Lymphoma, Non-Hodgkin
Drug: Rituximab
Drug: Lenalidomide

Phase 3

Celgene
Celgene

Seattle, Washington, United States and 125 other locations

This phase II trial studies how well pembrolizumab with rituximab or obinutuzumab work in treating patients with follicular lymphoma or diff...

Active, not recruiting
Recurrent Follicular Lymphoma
Refractory Follicular Lymphoma
Biological: Rituximab
Biological: Pembrolizumab

Phase 2

University of Washington
University of Washington

Seattle, Washington, United States

First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas....

Enrolling
Lymphoma, T-Cell
Diffuse Large B Cell Lymphoma
Drug: CPI-0209

Phase 1, Phase 2

Constellation Pharmaceuticals

Seattle, Washington, United States and 49 other locations

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...

Enrolling
Classic Follicular Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: Epcoritamab

Phase 2

Genmab
Genmab

Tacoma, Washington, United States and 52 other locations

This phase I/II trial studies the safety of acalabrutinib and axicabtagene ciloleucel in treating patients with B-cell lymphoma. Acalabrutin...

Enrolling
Grade 2 Follicular Lymphoma
Grade 1 Follicular Lymphoma
Biological: Axicabtagene Ciloleucel
Drug: Acalabrutinib

Phase 1, Phase 2

University of Washington
University of Washington

Seattle, Washington, United States

017 works in treating patients with non-Hodgkin's lymphoma whose disease has come back or has not responded to treatment....

Active, not recruiting
Follicular Lymphoma
Mantle-cell Lymphoma
Biological: JCAR017 (lisocabtagene maraleucel) single-dose schedule
Biological: JCAR017 (lisocabtagene maraleucel) 2-dose schedule

Phase 1

Juno Therapeutics

Seattle, Washington, United States and 13 other locations

dose of BGB-11417 monotherapy for relapsed or refractory mantle cell lymphoma. Part 2 evaluates efficacy of BGB-11417 monotherapy at the rec...

Enrolling
Mantle Cell Lymphoma
Relapsed Mantle Cell Lymphoma
Drug: BGB-11417

Phase 1, Phase 2

BeiGene
BeiGene

Puyallup, Washington, United States and 73 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems